National debts of Central Europe Genomics Center
The latest check (2025-06-28) in KRZ shows that Central Europe Genomics Center has 5 KRZ records. These records are distributed s follows: Discontinued enforcement proceedings - 3, Restructuring proceedings - 2.
Discontinued enforcement proceedings
Type of Proceedings | Case Number | Registration Date | Discontinuation Date | Status | Total |
---|---|---|---|---|---|
umorzone postępowanie egzekucyjne | 2004-SEE.7116.20.20337177.2023.6 | 2023-10-24 | 2024-03-12 |
completed
|
-1 111 287,06 PLN |
umorzone postępowanie egzekucyjne | 2004-SEE.7116.20.20849049.2023.6 | 2023-12-18 | 2024-03-12 |
completed
|
-1 774 762,50 PLN |
umorzone postępowanie egzekucyjne | 2004-SEE.7116.20.20849049.2023.6 | 2023-12-18 | 2024-03-12 |
completed
|
-740 085,75 PLN |
Restructuring proceedings
Type of Proceedings | Case Number | Registration Date | Discontinuation Date | Status | Total |
---|---|---|---|---|---|
postępowanie przed sądem restrukturyzacyjnym według przepisów k.p.c. | BI1B/GRo/6/2025 | 2025-04-10 | 2025-05-16 |
completed
|
- |
postępowanie o zatwierdzenie układu | BI1B/GRz-nu/22/2025 | 2025-02-13 | - |
! in progress
|
- |
We regularly monitor all companies in our database, including Central Europe Genomics Center, against the National Register of Debtors (KRZ) to identify any new entries.
Debt in companies can have a significant impact on their financial stability and future development. Companies often use loans or bonds to finance investments, but excessive debt can lead to liquidity problems and limit opportunities for further expansion. High liabilities can also affect the company's ability to pay suppliers and employees on time. Therefore, it is crucial to properly manage debt, negotiate favorable repayment terms, and avoid the risk of excessive debt, which can lead to insolvency or bankruptcy.